相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anticancer activity and DNA interaction of ruthenium acetate clusters bearing azanaphthalene ancillary ligands
Bruna Possato et al.
POLYHEDRON (2020)
β-Diketonate versus β-Ketoiminate: The Importance of a Ferrocenyl Moiety in Improving the Anticancer Potency
Matthew Allison et al.
CHEMBIOCHEM (2020)
Beyond Solvent Exclusion: i-Motif Detecting Capability and an Alternative DNA Light-Switching Mechanism in a Ruthenium(II) Polypyridyl Complex
Philip Spence et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Mononuclear ruthenium(ii) theranostic complexes that function as broad-spectrum antimicrobials in therapeutically resistant pathogens through interaction with DNA
Kirsty L. Smitten et al.
CHEMICAL SCIENCE (2020)
Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets
Adriana Pereira Mundim Guedes et al.
METALLOMICS (2020)
Using Nanoscopy To Probe the Biological Activity of Antimicrobial Leads That Display Potent Activity against Pathogenic, Multidrug Resistant, Gram-Negative Bacteria
Kirsty L. Smitten et al.
ACS NANO (2019)
Regulation of Gene Expression under Hypoxic Conditions
Koh Nakayama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Photoinduced anticancer effect evaluation of ruthenium(II) polypyridyl complexes toward human lung cancer A549 cells
Miao He et al.
POLYHEDRON (2019)
Anticancer, antifungal and antibacterial potential of bis(β-ketoiminato) ruthenium(II) carbonyl complexes
Cecilia R. Madzivire et al.
INORGANICA CHIMICA ACTA (2019)
Hypoxia-targeted drug delivery
Amit Sharma et al.
CHEMICAL SOCIETY REVIEWS (2019)
Solute-solvent electronic interaction is responsible for initial charge separation in ruthenium complexes [Ru(bpy)3]2+ and [Ru(phen)3]2+
Charles W. Stark et al.
COMMUNICATIONS CHEMISTRY (2019)
Applying a Trojan Horse Strategy to Ruthenium Complexes in the Pursuit of Novel Antibacterial Agents
Quentin Laurent et al.
ORGANOMETALLICS (2018)
Synthesis, characterization and antimicrobial activity of novel 3-ferroceny1-2-pyrazolyl-1,3-thiazolidin-4-ones
Anka Pejovic et al.
POLYHEDRON (2018)
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
Enzo Alessio
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Anticancer activity of heterodinuclear ruthenium(II)-platinum(II) complexes as photochemotherapeutic agents
Takakazu Yano et al.
INORGANICA CHIMICA ACTA (2017)
Ferrocene-steroid conjugates: Synthesis, structure and biological activity
Xiomara Narvaez-Pita et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2017)
Multimodal Super-resolution Optical Microscopy Using a Transition-Metal-Based Probe Provides Unprecedented Capabilities for Imaging Both Nuclear Chromatin and Mitochondria
Sreejesh Sreedharan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells
Cinara O. D'Sousa Costa et al.
ONCOTARGET (2017)
Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium
Jeannine Hess et al.
ACS INFECTIOUS DISEASES (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy
Franz Heinemann et al.
ACCOUNTS OF CHEMICAL RESEARCH (2017)
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Leli Zeng et al.
CHEMICAL SOCIETY REVIEWS (2017)
Bis-picolinamide Ruthenium(III) Dihalide Complexes: Dichloride-to-Diiodide Exchange Generates Single trans Isomers with High Potency and Cancer Cell Selectivity
Aida M. Basri et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Synthesis and Assessment of Antibacterial Activities of Ruthenium(III) Mixed Ligand Complexes Containing 1,10-Phenanthroline and Guanide
Atakilt Abebe et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2016)
Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy
Mohammad Abid et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
Martin R. Gill et al.
SCIENTIFIC REPORTS (2016)
Ruthenium complexes as antimicrobial agents
Fangfei Li et al.
CHEMICAL SOCIETY REVIEWS (2015)
Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis
Rianne M. Lord et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The comet assay: part, present, and future
Sabine A. S. Langie et al.
FRONTIERS IN GENETICS (2015)
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen et al.
INVESTIGATIONAL NEW DRUGS (2015)
Ruthenium(II) complexes containing functionalised β-diketonate ligands: developing a ferrocene mimic for biosensing applications
Yeng Ying Lee et al.
DALTON TRANSACTIONS (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
A New Age for Iron: Antitumoral Ferrocenes
Susana S. Braga et al.
ORGANOMETALLICS (2013)
Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters
Alexey A. Nazarov et al.
SCIENTIFIC REPORTS (2013)
Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents
Stephanie J. Lucas et al.
DALTON TRANSACTIONS (2012)
Luminescent Properties of Ruthenium(II) Complexes with Sterically Expansive Ligands Bound to DNA Defects
Anna J. McConnell et al.
INORGANIC CHEMISTRY (2012)
Ferrocenyl Derivatives of the Anthelmintic Praziquantel: Design, Synthesis, and Biological Evaluation
Malay Patra et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Crystal structure of Δ-[Ru(bpy)2dppz]2+ bound to mismatched DNA reveals side-by-side metalloinsertion and intercalation
Hang Song et al.
NATURE CHEMISTRY (2012)
A structural analysis of G-quadruplex/ligand interactions
Shozeb M. Haider et al.
BIOCHIMIE (2011)
Preparation and Biological Evaluation of Di-Hetero-Organometallic-Containing PNA Bioconjugates
Gilles Gasser et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2011)
Synthesis of Optically Active Ferrocene-Containing Platensimycin Derivatives with a C6-C7 Substitution Pattern
Malay Patra et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2011)
Antimicrobial activity of ruthenium-based intercalators
Albert Bolhuis et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) Complexes of the Benzimidazolylidene Type
Riccardo Rubbiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Interaction of [Ru(bpy)(2)(dppz)](2+) with human telomeric DNA: Preferential binding to G-quadruplexes over i-motif
Shuo Shi et al.
BIOCHIMIE (2010)
The Complex-in-a-Complex cations [(acac)(2)M subset of RU6(p-iPrC(6)H(4)Me)(6)(tpt)(2)(dhbq)(3)](6+): A Trojan horse for cancer cells
Bruno Therrien et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
Reactivity and Antiproliferative Activity of Ferrocenyl-Tamoxifen Adducts with Cyclodextrins against Hormone-Independent Breast-Cancer Cell Lines
Olivier Buriez et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
Synthesis and characterization of bis(bipyridine)ruthenium(II) complexes with bromo or protected ethynyl β-diketonato ligands
Sabrina Munery et al.
INORGANIC CHEMISTRY COMMUNICATIONS (2008)
Synthesis, characterization, and biological evaluation of novel ferrocene-triadimefon analogues
Zhong Jin et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2006)
A series of unconjugated ferrocenyl phenols:: Prospects as anticancer agents
Elizabeth Hillard et al.
CHEMMEDCHEM (2006)
Modification of the estrogenic properties of diphenols by the incorporation of ferrocene.: Generation of antiproliferative effects in vitro
A Vessières et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
FACS analysis of oxidative stress induced on tumour cells by SERMs
D Osella et al.
INORGANICA CHIMICA ACTA (2005)
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
YK Yan et al.
CHEMICAL COMMUNICATIONS (2005)
The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer
G Jaouen et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series:: Synthesis and biological behaviour
S Top et al.
CHEMBIOCHEM (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens:: Evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines
S Top et al.
CHEMISTRY-A EUROPEAN JOURNAL (2003)
New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes
ACG Hotze et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Synthesis and characterisation of some water soluble ruthenium(II)-arene complexes and an investigation of their antibiotic and antiviral properties
CS Allardyce et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2003)
Reactions of a ruthenium(II) arene antitumor complex with cysteine and methionine
FY Wang et al.
INORGANIC CHEMISTRY (2002)
分享论文
